17792
次閱讀

2026/6/6 新聞報導：東昕生醫發表 IRB 科學實驗，千人視力挑戰打破世界紀錄；2024 獲美國 FDA 進口許可。

Tung Sin Biomedical: 2026 news-featured IRB study, 1,000-person world-record vision challenge, and 2024 U.S. FDA import clearance.

東昕生醫在洪瑞昕醫師帶領研發下，推出新產品 愛新亮®。上市不到 1 年即創下亮眼銷售佳績，並透過「視力表體驗」活動推廣，以及連鎖眼科總院長推薦，讓品牌知名度大幅提升。目前已累積近 60,000 位全球愛用會員親身體驗，並加入品牌大使行列。

Under the research leadership of Dr. Jui-Shin Hung, Tung Sin Biomedical launched its new product, EYESBRIGHT® Lutein. Within less than 1 year of its launch, the product achieved strong sales performance. Through the “Eye Chart Experience” campaign and the recommendation of the general director of a chain ophthalmology clinic, the brand has gained significant recognition. Today, nearly 60,000 members worldwide have experienced EYESBRIGHT® and joined the brand ambassador community.

東昕生醫以「台灣聚熱、全球購物、世界加盟」為發展目標。第二階段全球購物已開始在各國累積許多愛用者，並持續推動世界 20 餘國加盟布局。我們誠摯歡迎各國經銷商與國際團隊，一同加入品牌大使行列，共創全球市場經營商機。

With the vision of “Building momentum in Taiwan, expanding global shopping, and developing worldwide franchise opportunities,” Tung Sin Biomedical is now advancing its second stage of global expansion. The brand continues to grow its user base across countries and promote franchise opportunities in more than 20 countries. We sincerely welcome international distributors and business teams to join our brand ambassador network and create new opportunities in the global market.